GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » FCF Margin %

MyndTec (XCNQ:MYTC) FCF Margin % : -365.22% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MyndTec FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. MyndTec's Free Cash Flow for the three months ended in Mar. 2024 was C$-0.25 Mil. MyndTec's Revenue for the three months ended in Mar. 2024 was C$0.07 Mil. Therefore, MyndTec's FCF Margin % for the quarter that ended in Mar. 2024 was -365.22%.

As of today, MyndTec's current FCF Yield % is -4.22%.

The historical rank and industry rank for MyndTec's FCF Margin % or its related term are showing as below:

XCNQ:MYTC' s FCF Margin % Range Over the Past 10 Years
Min: -932.03   Med: -790.31   Max: -247.52
Current: -461.68


During the past 4 years, the highest FCF Margin % of MyndTec was -247.52%. The lowest was -932.03%. And the median was -790.31%.

XCNQ:MYTC's FCF Margin % is ranked worse than
89.58% of 825 companies
in the Medical Devices & Instruments industry
Industry Median: -7.06 vs XCNQ:MYTC: -461.68


MyndTec FCF Margin % Historical Data

The historical data trend for MyndTec's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyndTec FCF Margin % Chart

MyndTec Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Margin %
-867.48 -247.52 -932.03 -713.14

MyndTec Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,128.95 -1,600.00 - -871.43 -365.22

Competitive Comparison of MyndTec's FCF Margin %

For the Medical Devices subindustry, MyndTec's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MyndTec's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MyndTec's FCF Margin % distribution charts can be found below:

* The bar in red indicates where MyndTec's FCF Margin % falls into.



MyndTec FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

MyndTec's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-0.977/0.137
=-713.14 %

MyndTec's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-0.252/0.069
=-365.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MyndTec FCF Margin % Related Terms

Thank you for viewing the detailed overview of MyndTec's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


MyndTec (XCNQ:MYTC) Business Description

Traded in Other Exchanges
N/A
Address
1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9
MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec (XCNQ:MYTC) Headlines

No Headlines